NEW YORK (GenomeWeb News) – Genetic Technologies today said that it has reached a settlement with Roche 454 Life Sciences over alleged infringement of Genetic Technologies' primary non-coding DNA patent.
The Australian firm said that it has reached a settlement, covenant, and license agreement with 454, which also covers its affiliates within Roche. The terms of the agreement are confidential.
Roche 454 was one of 10 firms named as defendants in a lawsuit filed by Genetic Technologies in May 2011 in the US District Court for the District of Colorado.
The firm said that discussions with other parties are "ongoing and progressing."